XML 95 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation
12 Months Ended
Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-Based Compensation

3.  Share-Based Compensation

Overview

As of December 31, 2013, the Company has two active equity compensation plans. A description of these plans is as follows:

Nonemployee Directors’ Deferred Stock Compensation Plan

Pursuant to the United Stationers Inc. Nonemployee Directors’ Deferred Stock Compensation Plan, non-employee directors may defer receipt of all or a portion of their retainer and meeting fees. Fees deferred are credited quarterly to each participating director in the form of stock units, based on the fair market value of the Company’s common stock on the quarterly deferral date. Each stock unit account generally is distributed and settled in whole shares of the Company’s common stock on a one-for-one basis, with a cash-out of any fractional stock unit interests, after the participant ceases to serve as a Company director. For the years ended December 31, 2013, 2012 and 2011, the Company recorded compensation expense of $0.1 million, $0.2 million, and $0.2 million, respectively. As of December 31, 2013, 2012 and 2011, the accumulated number of stock units outstanding under this plan was 56,737; 62,421; and 89,285; respectively.

Amended and Restated 2004 Long-Term Incentive Plan (“LTIP”)

In May 2011, the Company’s shareholders approved the LTIP to, among other things, attract and retain managerial talent, further align the interest of key associates to those of the Company’s stockholders and provide competitive compensation to key associates. Award vehicles include stock options, stock appreciation rights, full value awards, cash incentive awards and performance-based awards. Key associates and non-employee directors of the Company are eligible to become participants in the LTIP, except that non-employee directors may not be granted incentive stock options.

Accounting For Share-Based Compensation

The following table summarizes the share-based compensation expense (in thousands):

 

     Year Ended December 31,  
     2013     2012     2011  

Numerator:

      

Pre-tax expense

   $ 10,808      $ 8,746      $ 15,734   

Tax effect

     (4,108     (3,323     (5,977
  

 

 

   

 

 

   

 

 

 

After tax expense

   $ 6,700      $ 5,423      $ 9,757   
  

 

 

   

 

 

   

 

 

 

Denominator:

      

Denominator for basic shares—Weighted average shares

     39,650        40,337        43,822   

Denominator for diluted shares—Adjusted weighted average shares and the effect of dilutive securities

     40,236        40,991        45,014   

Net expense per share:

      

Net expense per share—basic

   $ 0.17      $ 0.13      $ 0.22   
  

 

 

   

 

 

   

 

 

 

Net expense per share—diluted

   $ 0.17      $ 0.13      $ 0.22   
  

 

 

   

 

 

   

 

 

 

The following tables summarize the intrinsic value of options outstanding, exercisable, and exercised for the applicable periods listed below:

Intrinsic Value of Options

(in thousands of dollars)

 

     Outstanding      Exercisable  

As of December 31, 2013

   $ 9,897       $ 6,262   

As of December 31, 2012

     8,420         8,420   

As of December 31, 2011

     13,668         13,668   

Intrinsic Value of Options Exercised

(in thousands of dollars)

 

For the year ended

      

December 31, 2013

   $ 13,676   

December 31, 2012

     2,380   

December 31, 2011

     8,911   

 

The following tables summarize the intrinsic value of restricted shares outstanding and vested for the applicable periods listed below:

Intrinsic Value of Restricted Shares

(in thousands of dollars)

 

Outstanding

      

As of December 31, 2013

   $ 47,780   

As of December 31, 2012

     40,222   

As of December 31, 2011

     32,634   

Intrinsic Value of Restricted Shares Vested

(in thousands of dollars)

 

For the year ended

      

December 31, 2013

   $ 12,414   

December 31, 2012

     8,812   

December 31, 2011

     27,576   

The aggregate intrinsic values summarized in the tables above are based on the closing sale price per share for the Company’s Common Stock on the last day of trading in each respective fiscal period which was $45.89, $30.99, and $32.56 per share for the 2013, 2012 and 2011 periods ended. Additionally, the aggregate intrinsic value of options exercisable does not include the value of options for which the exercise price exceeds the stock price as of the last day of trading in each respective fiscal period.

Stock Options

The fair value of option awards and modifications to option awards is estimated on the date of grant or modification using a Black-Scholes option valuation model that uses various assumptions including the expected stock price volatility, risk-free interest rate, and expected life of the option. The expected term of options granted is derived from the historical forfeiture and exercise behavior and represents the period of time that options granted are expected to be outstanding. The expected volatility of the price of the underlying shares is implied based on historical volatility of the Company’s common stock. The expected dividends were based on the current dividend yield of the Company’s stock as of the date of the grant. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The assumptions used are shown in the following table.

 

     2013  

Weighted average expected term

     5.6   

Expected volatility

     40.01—40.49

Weighted average volatility

     40.48

Weighted average expected dividends

     1.46

Risk-free rate

     0.76—1.62

Stock options granted in 2013 vest at the end of three years and have a term of 10 years. Previously issued stock options generally vested in annual increments over three years and have a term of 10 years. Compensation costs for all stock options are recognized, net of estimated forfeitures, on a straight-line basis over the vesting period. As of December 31, 2013, there was $4.7 million of unrecognized compensation cost related to stock option awards granted. The cost is expected to be recognized over a weighted-average period of 2.25 years. In 2013, there were 585,189 stock options granted. There were no stock options granted during 2012 or 2011.

 

The following table summarizes the transactions, excluding restricted stock, under the Company’s equity compensation plans for the last three years:

 

     2013     Weighted
Average
Exercise
Price
     2012     Weighted
Average
Exercise
Price
     2011     Weighted
Average
Exercise
Price
 

Options outstanding—January 1

     1,371,850      $ 24.86         1,715,380      $ 24.62         2,563,708      $ 24.18   

Granted

     585,189        38.71         —          —           —          —     

Exercised

     (1,065,920     24.69         (217,634     18.69         (847,528     23.26   

Cancelled

     (78,959     38.69         (125,896     32.35         (800     29.51   
  

 

 

      

 

 

      

 

 

   

Options outstanding—December 31

     812,160      $ 33.70         1,371,850      $ 24.86         1,715,380      $ 24.62   
  

 

 

      

 

 

      

 

 

   

Number of options exercisable

     305,930      $ 25.42         1,371,850      $ 24.86         1,715,380      $ 24.62   
  

 

 

      

 

 

      

 

 

   

The following table summarizes outstanding and exercisable options granted under the Company’s equity compensation plans as of December 31, 2013:

 

Exercise Prices

   Outstanding      Remaining
Contractual
Life (Years)
     Exercisable  

20.00—25.00

     201,684         2.3         201,684   

25.01—30.00

     102,000         3.7         102,000   

30.01—35.00

     2,246         3.4         2,246   

35.01—40.00

     506,230         9.3         —     
  

 

 

       

 

 

 

Total

     812,160         6.8         305,930   
  

 

 

       

 

 

 

 

Restricted Stock and Restricted Stock Units

The Company granted 181,916 shares of restricted stock and 166,348 restricted stock units (“RSU”s) during 2013. During 2012, the Company granted 461,512 shares of restricted stock and 245,737 RSUs. During 2011, the Company granted 30,097 shares of restricted stock and 332,888 RSUs. The restricted stock granted in each period generally vests in three equal annual installments on the anniversaries of the date of the grant. The majority of the RSUs granted in 2013, 2012 and 2011 vest in three annual installments based on the terms of the agreements, to the extent earned based on the Company’s cumulative economic profit performance against target economic profit goals. The performance-based RSUs granted in 2011 and 2012 have a minimum and maximum payout of zero to 150%. The performance-based RSUs granted in 2013 have a minimum and maximum payout of zero to 200%. Included in the 2013, 2012 and 2011 grants were 194,517; 426,064; and 147,843 shares of restricted stock and RSUs granted to employees who were not executive officers, as of December 31, 2013, 2012 and 2011, respectively. In addition, there were 23,898; 41,051; and 39,314 shares of restricted stock and RSUs granted to non-employee directors during the years ended December 31, 2013, 2012 and 2011, respectively. For the years ended December 31, 2013, 2012 and 2011, respectively, there were also 129,849; 240,134; and 175,828 shares of restricted stock and RSUs granted to executive officers. The restricted stock granted to executive officers vests with respect to each officer in annual increments over three years provided that the following conditions are satisfied: (1) the officer is still employed as of the anniversary date of the grant; and (2) the Company’s cumulative diluted earnings per share for the four calendar quarters immediately preceding the vesting date exceed $0.50 per diluted share as defined in the officers’ restricted stock agreement. As of December 31, 2013, there was $14.2 million of total unrecognized compensation cost related to non-vested restricted stock and RSUs granted. The cost is expected to be recognized over a weighted-average period of 1.9 years. A rollforward of the Company’s restricted stock and RSU grants during the last three years is as follows:

 

Restricted Stock and RSUs

   2013     Weighted
Average
Grant Date
Fair Value
     2012     Weighted
Average
Grant Date

Fair Value
     2011     Weighted
Average
Grant Date
Fair Value
 

Nonvested—January 1

     1,297,906      $ 28.61         1,002,125      $ 26.42         1,562,626      $ 20.13   

Granted

     348,264        38.28         707,249        27.84         362,985        30.81   

Vested

     (323,159     37.02         (324,345     22.00         (853,384     17.14   

Cancelled

     (281,822     30.04         (87,123     28.16         (70,102     21.97   
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Nonvested—December 31

     1,041,189      $ 31.24         1,297,906      $ 28.61         1,002,125      $ 26.42